MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    The mechanism of tremor-modulating properties of propranolol and primidone in essential tremor: A study with transcranial magnetic stimulation and eye blink classical conditioning paradigm

    K. Vogelnik, N. Prezelj, R. Perellon Alfonso, P. Klavžar, M. Gregorič Kramberger, D. Flisar, D. Georgiev, Z. Pirtošek, M. Kojović (Ljubljana, Slovenia)

    Objective: To explain central mechanisms of propranolol and primidone action and to study pathophysiology of essential tremor (ET). Background: Neurophysiological studies suggest that both motor…
  • 2019 International Congress

    Steroid-responsive myoclonus in the context of pembrolizumab treatment: a novel neurological phenotype.

    M. Murphy, S. O'Dowd, M. Alexander (Dublin, Ireland)

    Objective: To outline a novel immunologically-mediated neurological adverse event associated with the use of a medication class which has an expanding range of applications [1].…
  • 2019 International Congress

    The legacy of Charles David Marsden: A role model in the field of movement disorders

    G. Froehner, L. Zubko, M. Pedro Franco, A. Meira, F. Germinani, H. Teive (Curitiba, Brazil)

    Objective: The report provides material about David Marsden's life and achievements in Neurology and specially in Movement Disorders field. Background: Marsden obtained his Master’s degree…
  • 2019 International Congress

    Motor and non-motor symptoms differences between Vascular Parkinsonism (VP) and Parkinson’s Disease (PD) patients in early stages

    R. Raimundo, M. Mendes, R. Jesus, C. Azoia, A. Almeida, AG. Velon (Vila Real, Portugal)

    Objective: Compare motor and non-motor symptoms between VP and PD patients. Background: VP is usually described as “lower-body parkinsonism”, with early gait difficulties and postural…
  • 2019 International Congress

    Clinical-instrumental algorithm for assessment visuospatial dysfunction in patients with Parkinson’s disease

    K. Stepanchenko (Kharkiv, Ukraine)

    Objective: To study the features of visual spatial dysfunction (VSD) in patients with Parkinson's disease (PD) using modern clinical-neuropsychological, ophthalmological and neuroimaging methods. Background: Visual…
  • 2019 International Congress

    Non-motor symptoms burden grading in Parkinson disease with the Movement Disorders Society – Non-Motor Rating Scale (MDS-NMS)

    D. Weintraub, C. Rodriguez-Blazquez, A. Schrag, A. Rizos, KR. Chaudhuri, P. Martinez-Martin (Madrid, Spain)

    Objective: To identify cut-off points on the Movement Disorders Society – Non Motor Rating Scale (MDS-NMS) for non-motor symptoms (NMS) burden grading. Background: NMS burden…
  • 2019 International Congress

    Cognitive Profile of Patients with Parkinson´s Disease and Subthalamic Nucleus Deep Brain Stimulation

    E. Barbosa, J. Santos, H. Fichman (Rio de Janeiro, Brazil)

    Objective: Compare the ON and OFF cognitive performance of patients with PD receiving Subthalamic nucleus Deep Brain Stimulation (STN-DBS) using a computerized neuropsycological battery called…
  • 2019 International Congress

    Impaired fonction of mirror neurons and the role of levodopa in PD patients

    T. Danaila, P. Jaulent, C. Laurencin, J. Xie, H. Klinger, P. Krolak-Salmon, S. Thobois (Lyon, France)

    Objective: Study of the emotional mirroring and its modulation by levodopa treatment in fluctuating PD patients with no significant cognitive burden as assessed by regular…
  • 2019 International Congress

    BODILY AND FACIAL EMOTION RECOGNITION IN PARKINSON´S DISEASE

    Z. Kosutzka, P. Brandoburova, I. Straka, V. Veronika, P. Valkovic, M. Hajduk (Bratislava, Slovakia)

    Objective: The aim of the current study is to directly compare performance in recognition of facial and bodily emotions. Background: Patients with Parkinson´s disease (PD)  show…
  • 2019 International Congress

    A comparison of serial position effects between patients with MCI due to Parkinson’s disease and patients with MCI due to Alzheimer’s disease

    A. Meyer, I. Handabaka, MM. Ehrensperger, U. Gschwandtner, F. Hatz, AU. Monsch, RD. Stieglitz, P. Fuhr (Basel, Switzerland)

    Objective: To compare the serial position effects (SPE) between patients with Mild Cognitive Impairment (MCI) due to Parkinson’s disease (PD-MCI) and patients with MCI due…
  • « Previous Page
  • 1
  • …
  • 76
  • 77
  • 78
  • 79
  • 80
  • …
  • 217
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley